Intelligent Nanoparticle Synthesis, from High-Throughput Screening to Pilot Scale-Up
Microfluidic precision-mixing platforms for nanomedicine preparation — from 60 μL ultramicro-volume screening up to 500 mL/min pilot production, accelerating the development and industrialization of mRNA vaccines, LNPs, liposomes and polymeric nanoparticles.
Three Platforms Covering the Entire Nano-Formulation Workflow
High-throughput screening, benchtop development and pilot scale-up share the same microfluidic mixing principle and chip family — formulation parameters optimized in the lab transfer seamlessly to production scale.
High-Throughput · Ultramicro Screening
NP-HT.S High-Throughput NP Synthesis System
High-Throughput Nanoparticle Synthesis System
An ultramicro-volume screening platform with 8-channel parallel synthesis and 20–30 s per run: as little as 60 μL per channel, tubing-free zero-dead-volume chip, compact enough for biosafety cabinets.
8 channels in parallel — thousands of formulations per day
An intelligent benchtop synthesis platform with full touch-screen control of TFR/FRR and every process parameter — one-step formation, controlled particle size, high reproducibility.
Particle size 30–200 nm, FRR from 10:1 to 1:30
Sample volume 0.4–40 mL, standard 1–20 mL Luer syringes
Standard COC chip; 316L stainless / glass optional
A modular pilot-scale platform for LNPs, polymeric nanoparticles and emulsions, with optional heating, in-line dilution and automatic waste switching, compliant with 21 CFR Part 11.
Dual high-pressure + ambient channels, up to 500 mL/min
Non-contact mass flow meters with real-time feedback
Liquid path heatable to 80 °C; 316L tubing for cGMP
One platform family serving nucleic acid drugs, vaccines, delivery systems and advanced formulations across many nanoparticle preparation scenarios.
mRNA Vaccines & LNP Drugs
LNP formulation screening, process development and pilot scale-up for mRNA vaccines and siRNA therapeutics.
Liposome Formulations
Consistent preparation of conventional and novel lipid carriers with narrow size distribution and low batch-to-batch variability.
Polymeric Nanoparticles (PLGA)
Nanoprecipitation of biodegradable polymers such as PLGA and PCL for sustained-release formulations.
Exosome Drug Loading
Drug loading and post-processing of exosomes and extracellular vesicles as natural nanocarriers.
Nucleic Acid Delivery (DNA / RNA / RNP)
Payloads from DNA and RNA to RNP, peptides and small molecules — full coverage of gene-therapy payloads.
Cosmetic Nanoemulsions
Continuous preparation of nanoemulsions and lipid carriers for cosmetic active ingredients.
Technology
Microfluidic Mixing Technology
Nanoparticle self-assembly driven by precisely controlled hydrodynamics: total flow rate (TFR) governs particle size and mixing efficiency, while flow rate ratio (FRR) governs composition and nucleation — digital parameters, repeatable and scalable results.
1
Lipid / Organic Phase
Lipids or polymers dissolved in ethanol or other organic solvents
2
Precise Metering
Fully digital TFR and FRR setting with ±1–2% accuracy
3
On-Chip Mixing
Impinging jet / vortex / SAR mixing architectures
4
Self-Assembly
Supersaturation-driven assembly into uniform nanoparticles